HIGHLIGHTS
- who: Xing Lyu from the University, China have published the research: Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis, in the Journal: (JOURNAL)
- what: The authors propose an IL-23/IL-17 axis-based mechanistic model regarding intestinal inflammation driving immune damage in peripheral joints. The authors provide a summary of current clinical trials using probiotics for IBD in Table 2.
- future: The gut microbiome's plasticity has also prompted researchers to assess the viability of precision therapy based on the gut microbiome's SpA and to design new . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.